Yesodot Eitanim 2025: Equity improved, but value still has to pass the financing and execution test

Getting to Know the Company

Yesodot Eitanim looks on screen like a tiny listed real-estate stock, and in one sense that is true. As of early April 2026, market cap stood at about ILS 58.2 million, and the last daily turnover in the stock was only about ILS 37 thousand. But anyone who reads the company only through the market screen gets an incomplete picture. This is not a developer living off a single project. It is a small listed layer sitting above and inside a denser map of residential projects, urban renewal positions, land, investment property, and joint ventures.

What is working now is real. In 2025 the company materially reinforced its equity layer: it completed a public offering of shares and convertible bonds in March, a private placement in November, and equity rose to ILS 55.3 million from ILS 35.9 million at the end of 2024. At the same time, it is already building in three projects, Rezort Nes Ziona, Nofim Migdal HaEmek, and Yaarit Shlomi, and in December it also acquired additional land in Nes Ziona for a new 16-unit phase. In other words, the company is no longer fighting only for basic public-market oxygen. It has a platform, it has a pipeline, and it has better balance-sheet room.

But the picture is still not clean. Revenue fell 24.3% to ILS 57.0 million, gross profit dropped to only ILS 9.7 million, and the company moved to a net loss of ILS 10.2 million. A reader who looks only at the consolidated accounts may conclude the company is smaller and weaker than it really is. A reader who looks only at the project map may conclude the value is already there. Both readings are partial. A meaningful part of the activity sits in joint operations and equity-accounted holdings, so it does not reach common shareholders at the same speed at which it appears in the broader business footprint.

That is the core of the 2025 thesis. Equity is less of a choke point, but value is still not accessible. For land, projects, and partnerships to become real value for shareholders, the company still has to pass a set of practical gates: refinancing, formal construction finance, sales pace, execution pace, and the ability to pull cash out of joint structures rather than only carry them in the accounts.

There is also a practical actionability limit right now. The company has no short-interest data available, but even without a short layer the trading data shows extremely weak liquidity. This is a stock that can trade for days on very low turnover. So even if the business thesis improves, the path from economic value to accessible market value still runs through time, financing, and execution, not just through one accounting line.

Quick economic map

That chart sets the base read immediately. 2025 is not a balance-sheet collapse year. It is a year of weaker surface-level results, precisely after a financing move that expanded the equity layer and gave the company more room to maneuver.

The company employs only 19 people including consolidated subsidiaries, and also operates through a wholly owned execution subsidiary. That matters because this is not a passive holding shell. It moves between development, execution, project management, partnerships, and investment property. That complexity creates optionality, but it also means the consolidated report is smaller than the underlying business footprint.

Events and Triggers

The 2025 capital raises changed the starting point

The first trigger: in March 2025 the company became a public company and issued 5,875,000 ordinary shares alongside ILS 29.375 million par value of Series B convertible bonds. Later, in November 2025, it completed a private placement of 3,683,823 shares plus 3,274,510 warrants for total consideration of ILS 12.9 million. In plain terms, the equity base jumped to ILS 55.3 million.

The second trigger: that improvement is already visible in the bond metrics. The minimum required equity under the convertible bond indenture is ILS 18 million, and the minimum equity-to-net-balance-sheet ratio is 16%. At the end of 2025, the company stood at roughly ILS 55 million of equity and a 27.7% ratio. So the 2025 story is not one of tight covenants. The story is what management now does with the extra room.

New land and old debt now sit on the same junction

The third trigger: in December 2025 the company acquired Rezort Phase B in Nes Ziona, land for 16 units held 100%. Accumulated cost at year-end was ILS 36.8 million, and the company estimated another ILS 47.1 million of completion cost still ahead. On paper this looks like a new growth engine, with expected revenue of ILS 99.7 million, expected cost of ILS 83.9 million, and expected gross profit of ILS 15.8 million.

But this is where the practical test starts. The financing agreement for that phase was signed only in December, and the loan was drawn only in January 2026. In addition, the construction phase depends, among other things, on at least 20% presales in the new phase, 90% sales in the existing Rezort project, and 60% completion in the existing project. At the end of 2025, the existing Rezort project was still at 80% sales. So even the new engine is not truly free-standing. It sits behind financing and execution gates.

The fourth trigger: on the other side of the map sits Rehovot. The company and its partner acquired land for a 39-unit project, and the bank financing tied to that land was extended again to May 19, 2026. Both the February 2026 immediate report and the annual note say the same thing: no other financing terms were changed, only the maturity was pushed again. This is not a technical detail. It is a reminder that part of the company’s value still sits on bridge financing for land that has to move into a more advanced project stage.

The projects are moving, but not at the same quality level

The fifth trigger: Rezort Nes Ziona is progressing reasonably well. At the end of 2025, 35 contracts had been signed out of 44 units, implying an 80% sales rate. Engineering completion stood at 70.8% for Phase A, 23% for Phase B, and 3% for Phase C. This is a project that is moving in both execution and sales.

The sixth trigger: Migdal HaEmek looks different. In the Nofim project, 45 units had been sold out of 146 by year-end, and Phase A had already reached 76.5% completion. But expected gross profit for the whole project had eroded to only ILS 6.7 million, roughly 1% of expected revenue. That means the sales progress matters, but it is not sufficient. If financing and execution costs do not settle, the project can remain large in volume and weak in economic value.

That chart highlights the gap between progress and quality. Rezort already looks like a relatively advanced project. Migdal HaEmek is still heavier, both in scale and in its ability to convert sales into net profit and distributable surplus.

The seventh trigger: in Shlomi the direction also changed. After the war-related delays, the company resumed fuller execution, and close to the report date Phase A had already reached 66.5% completion with 11 units sold. In December 2025, rights to 38 units in Stages B and C were also sold to a third party. That does not make the region clean of risk, but it does show the company actively trying to reduce capital load in a sensitive project.

Efficiency, Profitability and Competition

The central 2025 story is deterioration in earnings quality, not disappearance of activity. Revenue fell to ILS 57.0 million, mainly because apartment sales dropped to ILS 33.5 million from ILS 62.4 million in 2024. At the same time, construction-contracting revenue rose to ILS 22.1 million from ILS 11.2 million. So activity did not freeze. It shifted into a different mix.

The problem is that this mix did not translate into margin. Cost of revenue barely fell, to ILS 47.3 million from ILS 49.5 million, so gross profit compressed to only ILS 9.7 million. Gross margin fell to roughly 17% from roughly 34% in 2024. After ILS 10.6 million of G&A, ILS 1.7 million of selling costs, ILS 3.0 million of share in partnership losses, and ILS 6.2 million of net finance expense, the company moved into a loss.

What matters here is not only the total. It is also what carried the year. In 2024 the company relied more on apartment sales. In 2025 it leaned more on contracting work while apartment sales weakened. For a residential developer, that is almost always a less favorable margin mix.

The consolidated report is smaller than the activity, but not all of that activity helps right now

This is the point most readers are likely to miss. According to the segment table, 2025 residential-development revenue on the company-share basis stood at ILS 70.9 million, above the ILS 57.0 million recognized on a consolidated basis. In practice, there is more activity than what appears on the top line.

But that does not automatically make the gap good news. Part of this broader activity sits in partnerships and held entities that are still losing money or at least not releasing value quickly. The Migdal HaEmek partnership generated a company share of loss of ILS 3.6 million in 2025, while Groupit contributed only ILS 149 thousand to the company’s earnings line even though it sits on more meaningful income-producing property.

That gap matters because it explains why the market can read the company in two opposite ways. On one hand, the economic footprint is broader than the report. On the other hand, part of the value sits in layers that still do not translate into net profit or cash at the listed-company level.

Who is paying for the sales pace

Another sharper issue sits inside the marketing models. The company explicitly says that during 2025 it gave some customers greater payment flexibility through 20/80 or 40/60 structures. It also says it does not currently expect a material exposure from that, but adds that if the market continues to work this way more aggressively, profitability could erode. That is exactly the kind of sentence the market tends to skim past even though it says something very simple: even if sales pace is maintained, the quality of that pace may already be weaker economically.

The company adds that the cost of these models is already reflected as a meaningful finance component in the accounts. That means 2025 cannot be read only through the revenue line. It also has to be read through who is effectively financing the selling terms.

Revenue recognition itself adds sensitivity

The auditors flagged progress measurement as a key audit matter. Revenue is recognized over time based on incurred costs relative to expected total costs, while excluding land cost, levies, and financing cost from the progress metric. In a company of this size, where every meaningful project can move the picture, any change in cost estimates or execution pace can quickly affect reported earnings.

So 2025 is not only a year of weaker apartment sales. It is also a year in which accounting recognition is highly sensitive to estimates, while sales quality is being tested in a less comfortable market environment.

Cash Flow, Debt and Capital Structure

The all-in cash picture

To understand 2025, the right frame here is all-in cash flexibility, not normalized cash generation. The question is not how much cash the business could generate in a more comfortable world. The question is how much cash really remained after actual cash uses. On that test, the year does not look strong.

The company started 2025 with ILS 11.2 million of cash and cash equivalents, generated ILS 12.7 million from operating activity, used ILS 9.8 million in investing activity, and added only ILS 3.3 million net from financing activity. It ended the year with ILS 17.5 million of cash. That is not a liquidity crisis, but neither is it a thick cushion for a company managing inventory, land, and several projects in parallel.

Even that chart is a little too mild unless one adds the most important fact: during 2025 the company also acquired land against credit in the amount of ILS 44.4 million, without immediate cash outflow. In other words, year-end cash looked somewhat easier than it would have looked had the new Nes Ziona land been paid for in cash.

Working capital looks weak, but not under the same lens in both frames

On the standard accounting view, the company does have a working-capital deficit. In its working-capital table it presents current assets of ILS 123.8 million against current liabilities of ILS 126.5 million. But the same table also presents an alternative 12-month view: after adjustments related to the Rehovot project and Rezort, the picture becomes ILS 73.1 million of assets versus ILS 59.0 million of liabilities, meaning a positive ILS 14.1 million gap.

That is not a contradiction. It is a framing issue. The accounts say the company relies on relatively short financing and on classifications that compress the picture. Management says part of those items are not truly a 12-month problem because they relate to projects whose monetization horizon is longer. Both claims are valid, so the conclusion also has to be two-sided: there is no extreme near-term liquidity hole right now, but there is clear dependence on debt extensions and on transition into formal project finance.

Debt is shorter than before, but still sits on extension tests

Current financial debt and credit from financiers fell to ILS 57.0 million from ILS 86.6 million in 2024. That is an important improvement. But it does not mean the issue is solved. Inside that figure sits a ILS 14.5 million loan from a financial institution, at prime plus 6% to 6.5%, secured by a pledge over Groupit shares. Its maturity is May 18, 2026, so even after the reduction in current debt the company still enters 2026 with a clear corporate-level timing test.

Alongside that sits a third-party loan of ILS 2.1 million, at 7% annual interest, due on May 19, 2026. So even at the narrower corporate layer, 2026 begins with several clear timing tests.

The Series B convertible bond looks quieter. Liability balance stood at ILS 28.1 million, final maturity is only in June 2028, and the stated coupon is 5%. Beyond that, the company is currently well away from the bond covenants. The Yesodot Eitanim issue is not Series B. It is land-stage projects and bridge finance.

Part of the real pressure sits above the company layer too

A reader who looks only at consolidated debt misses another layer. According to the company’s own sensitivity analysis, it had roughly ILS 58 million of prime-based debt on a consolidated basis. A 1% rise in the Bank of Israel rate would increase annual finance expense by about ILS 0.6 million at a similar debt level. But the company’s held entities also carry prime-based debt of about ILS 266 million, of which the company’s share is about ILS 122 million. So even if the consolidated balance sheet looks more orderly, rate sensitivity has not really disappeared. It has simply been dispersed across layers.

Another practical and unintuitive point is that the company itself has only ILS 0.5 million of general, non-project-specific credit lines. In other words, the non-project corporate safety margin is thin. Most flexibility comes from equity, capital raises, debt extensions, and the ability to move projects into proper financing structures.

Outlook

First finding: 2026 looks like a financed bridge year, not a clean breakout year. The 2025 capital raises solved part of the balance-sheet issue, but they did not solve the translation problem from land and partnerships into surplus cash and actual liquidity.

Second finding: Rehovot and Rezort Phase B are financing tests, not only development tests. An extended maturity is not a substitute for a project actually moving into a structure that can fund itself more cleanly.

Third finding: Migdal HaEmek is a quality test. It is a project with meaningful sales progress, but with only around 1% expected gross margin. If that margin does not improve, quantitative progress may still fail to produce meaningful economic value.

Fourth finding: a meaningful part of the upside sits in assets and partnerships above the common-shareholder layer, income-producing real estate through Groupit and Park Kinneret, commercial partnerships, and a large urban-renewal pipeline. This is real value, but not value that arrives automatically.

The right name for 2026 is therefore a transition year with an execution and financing test. If the market looks for cleaner headline net profit in the coming quarters, it may be disappointed. If it looks instead for signs that the company can extend financing, improve sales quality, protect margins in the larger projects, and make higher-layer value more accessible, it will get a more relevant read.

What has to happen over the next 2 to 4 quarters

What could improve the market read is a combination of small but meaningful signals: another financing extension that does not come under visible stress, progress at Rezort and Migdal HaEmek without another margin deterioration, and preservation of the stronger equity base without the need for another capital injection. What could weigh on the story is the exact opposite: frequent maturity pushes, sales pace that is preserved only through softer payment terms, and a larger share of the business moving into the category of looking good on the map while still failing to send cash to shareholders.

Risks

The first risk is bridge financing. Even if equity has improved, several of the key 2026 pressure points still sit on relatively short loans or on rolled maturities, in Rehovot, in the loan secured by Groupit shares, and in the third-party loan. Until projects move deeper into formal construction finance and actual surplus release, these extensions remain part of the ongoing story.

The second risk is sales quality. The company itself says that in order to stay competitive it gave customers more payment flexibility in 2025 through 20/80 and 40/60 structures. It says current exposure is not material, but in the same breath says that if the market requires more of these models, profitability may erode. That is not a footnote. It is a mechanism that can preserve sales pace while weakening growth quality.

The third risk is the gap between created value and accessible value. Investments in held entities stood at ILS 52.8 million at year-end, almost as large as total equity. But part of that value sits in Groupit, Migdal HaEmek, commercial centers, and joint structures with partners, leverage, guarantees, and minority interests. As long as that value does not travel up the chain, it can look large and still remain far from the common shareholder.

The fourth risk is execution cost and rates. The company explicitly says the war caused meaningful construction-input inflation and weaker demand, and that the Shlomi and northern activity also suffered operational delays. At the same time, rate sensitivity exists both on a consolidated basis and inside the held entities. In a company of this size, where each larger project moves the picture more sharply, these two variables can quickly move the margin.

The fifth risk is liquidity in the stock itself. Even without short-interest data, trading turnover shows that the share does not offer a deep market. In a company like this, even better fundamentals can take time to translate into market value simply because the distance between economic value and accessible market value is wider.

On the legal side, the company does not report material legal proceedings, but by the end of 2025 it had already booked a ILS 1.649 million provision for claims and defect liabilities, and after the balance sheet date it also received a homeowner claim in the Neve HaTut project for ILS 986 thousand, for which it says a sufficient provision has already been made. These are not existential risks, but they do remind the reader that in a company of this size even smaller events can still eat into the bottom line.

Conclusions

Yesodot Eitanim exits 2025 with stronger equity but not with cleaner underlying economics. That is the key difference between this year and the shallow first read. The company no longer looks like an entity fighting only for basic balance-sheet oxygen. But a large part of what looks like value still sits in land, partnerships, rolled financing, and projects that have yet to prove a full path to surplus cash.

Current thesis: equity improved, but value at Yesodot Eitanim still has to pass a financing and execution test before it becomes accessible to shareholders.

What changed: in 2024 it was easier to read the company mainly through capital pressure and the transition into the public market. In 2025, after the public issuance and the private placement, the focus shifted from lack of capital to whether the new capital actually helps unclog Rehovot, Rezort, Migdal HaEmek, and the broader holding layer.

Counter-thesis: it is possible to argue the market is already too cautious. Equity is now almost equal to market cap, Rezort is progressing, a new land position with attractive expected profitability has been added, and some of the held activities contain income-producing real-estate value that the consolidated report does not properly show. If several financing tests clear together, the read could improve faster than it currently seems.

What could change near-term market interpretation: not so much the headline annual figures, but rather financing extensions or a shift into formal project finance, sales progress in Rezort and Migdal HaEmek, and signals that higher-layer value is becoming more accessible.

Why this matters: in a small real-estate company with many joint structures, the question is not only whether value is being created. The question is in which layer it is created, who is financing the wait for it, and when it actually reaches the common shareholder.

What has to happen in the next 2 to 4 quarters: Rehovot has to move beyond repeated short maturity pushes, Rezort has to advance toward the sales levels that make Phase B easier to activate, Migdal HaEmek has to show that a 1% gross margin is not its ceiling, and the company has to prove that value outside the consolidated report can actually move up the chain.